| Perceived benefits would be to:
| Give women more choices to better meet their needs Increase client satisfaction Reduce the frequency of clinic visits Reduce travel time and costs to users
|
Expand the pool of users Reduce supply chain costs to governments, including through potentially simplified product procurement logistics and storage Reduce the burden on providers
| Increase privacy due to fewer facility visits Make reinjection window and appointments easier to remember Potentially reduce the time to return to fertility Potentially reduce side effects Increase shared decision-making and couple communication
|
| Perceived challenges would be to:
| Possibly pay a higher cost Navigate a narrower reinjection window and/or longer time between doses (e.g., client trouble returning on time; less flexibility to manage schedules) Reduce provider/client interaction opportunities Understand and navigate whether/how the different duration-of-effectiveness windows impact side effects
|
Create potential confusion among clients (e.g., differentiating between methods) Maintain sufficient stock Navigate client counseling on the new method Add extra reporting burden
| |